CARB-X In the News

In the News

  • 04.17.2024  |  As antimicrobial resistance looms large, a nonprofit teams up with Big Pharma to intervene

    PharmaVoice |AMR is a growing threat, but with little financial incentive to pick up the torch, government and nonprofit collaborations are keeping the R&D flames burning.

    Full Story

  • 03.08.2024  |  Professor Kevin Outterson speaks on antimicrobial resistance

    TUFTS DAILY | Kevin Outterson, a professor at Boston University, bridges economics, health equity and scientific research in his discussion about how to combat antimicrobial resistance.

    Full Story

  • 03.06.2024  |  CARB-X Funds 100th Project—a Milestone for BU-Based Nonprofit Leading Antimicrobial-Resistance Fightback

    THE BRINK | Global partnership led by BU law professor has now given $452.6 million in funding to support promising new antibiotics, vaccines, and rapid diagnostics—and is ready to support more projects.

    Full Story

  • 03.05.2024  |  With new award, CARB-X hits the 100-project mark in battling antibiotic resistance

    CIDRAP | CARB-X today announced funding for its 100th project addressing antimicrobial resistance (AMR).

    Full Story